These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16081317)

  • 1. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.
    Lötzer K; Funk CD; Habenicht AJ
    Biochim Biophys Acta; 2005 Sep; 1736(1):30-7. PubMed ID: 16081317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of leukotrienes in allergic diseases.
    Liu M; Yokomizo T
    Allergol Int; 2015 Jan; 64(1):17-26. PubMed ID: 25572555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid metabolites: mediators of inflammation in asthma.
    Wenzel SE
    Pharmacotherapy; 1997; 17(1 Pt 2):3S-12S. PubMed ID: 9017783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease.
    Poeckel D; Funk CD
    Cardiovasc Res; 2010 May; 86(2):243-53. PubMed ID: 20093252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis.
    Lötzer K; Spanbroek R; Hildner M; Urbach A; Heller R; Bretschneider E; Galczenski H; Evans JF; Habenicht AJ
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e32-6. PubMed ID: 12816882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.
    Spanbroek R; Grabner R; Lotzer K; Hildner M; Urbach A; Ruhling K; Moos MP; Kaiser B; Cohnert TU; Wahlers T; Zieske A; Plenz G; Robenek H; Salbach P; Kuhn H; Radmark O; Samuelsson B; Habenicht AJ
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1238-43. PubMed ID: 12552108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling.
    Shim YM; Zhu Z; Zheng T; Lee CG; Homer RJ; Ma B; Elias JA
    J Immunol; 2006 Aug; 177(3):1918-24. PubMed ID: 16849505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice.
    Mehrabian M; Allayee H; Wong J; Shi W; Wang XP; Shaposhnik Z; Funk CD; Lusis AJ
    Circ Res; 2002 Jul; 91(2):120-6. PubMed ID: 12142344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways.
    Bugajev V; Paulenda T; Utekal P; Mrkacek M; Halova I; Kuchar L; Kuda O; Vavrova P; Schuster B; Fuentes-Liso S; Potuckova L; Smrz D; Cernohouzova S; Draberova L; Bambouskova M; Draber P
    J Lipid Res; 2021; 62():100121. PubMed ID: 34560079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis.
    Vila L
    Med Res Rev; 2004 Jul; 24(4):399-424. PubMed ID: 15170590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes in pulmonary arterial hypertension.
    Tian W; Jiang X; Sung YK; Qian J; Yuan K; Nicolls MR
    Immunol Res; 2014 May; 58(2-3):387-93. PubMed ID: 24570092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of antileukotriene drugs in atherosclerosis.
    Spanbroek R; Habenicht AJ
    Drug News Perspect; 2003 Oct; 16(8):485-9. PubMed ID: 14668944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for the macrophage 5-lipoxygenase pathway in aortic aneurysm development in apolipoprotein E-deficient mice?
    Funk CD; Cao RY; Zhao L; Habenicht AJ
    Ann N Y Acad Sci; 2006 Nov; 1085():151-60. PubMed ID: 17182931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotrienes and atherosclerosis.
    Riccioni G; Bäck M; Capra V
    Curr Drug Targets; 2010 Jul; 11(7):882-7. PubMed ID: 20388065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.
    Colazzo F; Gelosa P; Tremoli E; Sironi L; Castiglioni L
    Mediators Inflamm; 2017; 2017():2432958. PubMed ID: 28932020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous anesthetic propofol suppresses leukotriene production in murine dendritic cells.
    Inada T; Ueshima H; Shingu K
    J Immunotoxicol; 2013; 10(3):262-9. PubMed ID: 22953970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current view on the role of leukotrienes in atherogenesis.
    Jawien J; Korbut R
    J Physiol Pharmacol; 2010 Dec; 61(6):647-50. PubMed ID: 21224494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.